Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612102 · ClinicalTrials.gov registry record · NA
Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism
A NA study of Selective Mutism, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03612102 is a NA study of Selective Mutism that has completed, run by Florida International University. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03612102, a NA study of Selective Mutism, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This goal of this study is to evaluate an intensive group behavioral treatment (IGBT) program for children with selective mutism, a low base-rate childhood anxiety disorder. 29 children between the ages of 5 and 9 will be randomly assigned to participate in a 5-day IGBT over the summer or to a waitlist control condition, with the opportunity to participate in IGBT 4 weeks later. All children that participate in treatment will be followed up 8 weeks into the following school year.
Conditions Studied
Interventions
- BEHAVIORAL Intensive Group Behavioral Treatment (IGBT)
Study Locations (1)
Florida
- Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-02-11 |
| Est. Completion | 2017-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612102
The ClinicalTrials.gov registry entry for NCT03612102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Selective Mutism appearing as the primary indexed condition, and to 1 intervention - of which Intensive Group Behavioral Treatment (IGBT) is the first listed.
NCT03612102 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03612102 about?
NCT03612102 is a clinical study titled "Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism". This goal of this study is to evaluate an intensive group behavioral treatment (IGBT) program for children with selective mutism, a low base-rate childhood anxiety disorder. 29 children between the ages of 5 and 9 will be randomly assigned to participate in a 5-day IGBT over the summer or to a waitl...
What is the current status of trial NCT03612102?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-02-11. Estimated completion is 2017-12-14.
What conditions does trial NCT03612102 study?
This clinical trial studies the following conditions: Selective Mutism.
What interventions are being tested in trial NCT03612102?
The interventions under investigation include: Intensive Group Behavioral Treatment (IGBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03612102?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03612102 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Selective Mutism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.